Results 191 to 200 of about 12,349 (241)

Management of hereditary angioedema with normal C1Inh: a series of 163 French patients. [PDF]

Orphanet J Rare Dis
Bocquet A, Bouillet L, Hardy G, Boccon-Gibod I, Deroux A, Arnaud M, Pelletier F, Thanh AD, Ozanne N, Armengol G, Jeandel PY, Sailler L, Taquet MC, Launay D, Fain O, Gobert D.   +15 more
europepmc   +1 more source

Lanadelumab in Hereditary Angioedema: Real-World Outcomes and Implications for Access Practices in Europe. [PDF]

J Clin Med
Różyk D, Wrona W, Kucharczyk B, Tomaszewska A, Kucharczyk A.   +4 more
europepmc   +1 more source

Efficacy and acceptability of lanadelumab for long-term prophylaxis in hereditary angioedema: A Chinese multicenter real-world analysis. [PDF]

World Allergy Organ J
Xu Y, Ji R, Liu J, Cui X, Zhang H, Cao N, Yu Y, Li Y, Lai H, Zhi Y.   +9 more
europepmc   +1 more source

Achieving a normal life in hereditary angioedema: Quality of life and treatment gaps among German HAE patients. [PDF]

Allergol Select
Magerl M, Buttgereit T, Martinez-Saguer I, Staubach-Renz P, Greve J, Aygören-Pürsün E, Schauf L, Schön K.   +7 more
europepmc   +1 more source

A Comprehensive Assessment of Health-Related Quality of Life in Hereditary Angioedema as a Patient-Centered Approach. [PDF]

Int Arch Allergy Immunol
Yalcin Gungoren E, Karabiber E, Yorgun Altunbas M, Can S, Tusuz Onata E, Atik O, Dikici U, Meric Z, Ozanli I, Amirov R, Ozturk N, Bozkurt S, Eser Simsek I, Kiykim A, Ozek Yucel E, Bogatekin G, Aydogan M, Tepetam FM, Ozdemir O, Yilmaz EA, Mete Gokmen EN, Bilgic-Eltan S, Baris S, Ozen A, Karakoc-Aydiner E.   +24 more
europepmc   +1 more source

Hereditary Angioedema Prophylaxis Therapy: Berotralstat and Lanadelumab Safety Profile. [PDF]

Medicina (Kaunas)
Donadoni M, La Cava L, Bizzi E, Popescu Janu V, Meschia A, Cirigliano F, Cogliati C, Gidaro A.   +7 more
europepmc   +1 more source

Perioperative Hereditary Angioedema Triggered by Laryngeal Mask Airway: A Case Report and Anesthetic Implications. [PDF]

Cureus
Pulitanò R, Misiti FR, Isidori L, Giudice M, La Verde F.   +4 more
europepmc   +1 more source

The power of a pill: Ekterly (Sebetralstat): first oral on-demand therapy for hereditary angioedema-a paradigm shift in treatment. [PDF]

Ann Med Surg (Lond)
Bukhari SMR, Rashidi R.
europepmc   +1 more source

Long-term effectiveness and safety of lanadelumab in Canadian patients with hereditary angioedema: a subanalysis of the EMPOWER study. [PDF]

Allergy Asthma Clin Immunol
Betschel SD, Chapdelaine H, Gagnon R, Goodyear MD, Keith PK, El-Zoeiby A, Khutoryansky N, Castaner DN.   +7 more
europepmc   +1 more source

Attack rate reductions following berotralstat initiation among US patients with hereditary angioedema in the real-world. [PDF]

Allergy Asthma Clin Immunol
Davis-Lorton M, Tachdjian R, Lopez-Gonzalez L, MacKnight SD, Ramasubramanian R, Laliberté F, Gillard P, LiVecchi M, Nestler-Parr S, Lumry WR.   +9 more
europepmc   +1 more source